Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
VIEWORKS
Advantech Europe

New Limits to Magnesium for Preventing Preterm Labor

By HospiMedica International staff writers
Posted on 14 Jun 2013
The US Food and Drug Administration (FDA; Silver Spring, MD, USA) advise clinicians not to give pregnant women magnesium sulfate (MgSO4) for more than 5–7 days, as it may harm developing fetal bones.

The FDA decision was based on a review of 18 case reports in the agency's Adverse Event Reporting System; in these cases, women were given the drugs for an average of 9.6 weeks, for an average total dose of 3,700 mg over treatment period. Abnormalities resulting in their offspring included fractures of the long bones and ribs, which may have been caused by fetal hypermagnesemia and the resulting hypocalcemia.

The FDA also reviewed the epidemiologic evidence. In one study, significantly more bone anomalies were seen in newborns that had been exposed to MgSO4 for more than one week, compared with only three days of exposure. Another study found differences in levels of osteocalcin, magnesium, calcium, and phosphorus at birth in babies exposed for longer than a week. The abnormalities seen in neonates in both studies after MgSO4 exposure of more than 5–7 days included radiographic findings of radiolucent transverse metaphyseal bands of long bones such as the humerus.

The FDA will change the teratogenicity category of MgSO4 from Pregnancy category D, rather than A, and a warning that longer off-label administration for tocolysis can lead to low calcium levels and osteopenia or fractures in the baby will be added to the drug's labeling. The labeling will also be amended to stress that injectable MgSO4 is not indicated for prevention of preterm labor, that its efficacy and safety for this use have not been established, and that it should only be administered by trained healthcare professionals in well-equipped hospitals.

“Pregnant women should discuss with their healthcare professional the possibility of going into labor before term and the risks and benefits of any treatments that may be used,” stated the FDA advisory. “However, the long-term significance of these findings is not known because of inadequate follow-up, and it is unknown whether a shorter duration of treatment is associated with calcium and bone abnormalities in the neonate.”

MgSO4 is an inorganic salt containing magnesium, sulfur, and oxygen, and is the first-line anti-arrhythmic agent for torsades de pointes in cardiac arrest. It is also used as a bronchodilator in severe exacerbations of asthma, and to treat eclampsia in pregnant women. It delays labor by inhibiting uterine muscle contraction in the case of premature labor. A recent systematic review suggests that antenatal intravenous MgSO4 can also reduce the risk of cerebral palsy and gross motor dysfunction in preterm infants by on average 30%.

Related Links:
US Food and Drug Administration




Channels

Critical Care

view channel
Image: The miniature Proxima Sensor and dedicated bedside monitor (Photo courtesy of Sphere Medical).

In-Line Analyzer Monitors Blood Gases Bedside

A novel miniaturized blood gas analyzer delivers true point-of-care testing (POCT), enabling fast response and proactive critical care. The Proxima system includes the miniature Proxima Sensor and... Read more

Surgical Techniques

view channel

Restricting Transfusions After Cardiac Surgery Shows No Benefit

A new study concludes that there is no health advantage if doctors wait until a heart surgery patient becomes substantially anemic before receiving a transfusion. Researchers at the University of Leicester (United Kingdom), Bristol Royal Infirmary (BRI; United Kingdom), and other institutions conducted a multicenter,... Read more

Health IT

view channel
Image: ResolutionMD across multiple devices (Photo courtesy of Calgary Scientific).

Healthcare Communication Platform Offers Seamless Image Access

Novel diagnostic medical imaging software offers better access to health information, supports increased teamwork, and enhances communication among practitioners and patients. ResolutionMD enables doctors... Read more

Business

view channel
Image: An Air Evac Lifeteam Bell 206 Long Ranger helicopter (Photo courtesy Air Evac Lifeteam).

KKR Seals Deal to Buy Air Medical Group for USD 2 Billion

KKR (New York, NY, USA) have agreed to acquire Air Medical Group Holdings (AMGH; Lewisville, TX, USA), a leading provider of air ambulance services, in a deal valued at USD two billion, including debt.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.